Parvovirus (Erythrovirus) B-19 ASR
Description:The Parvo B19 ASR contains primers and a FAM-labeled probe targeting the VP1 gene of Parvovirus B19. In addition, the Parvo B19 ASR contains primers and a Texas Red-labeled probe for an internal control sequence. This ASR requires an instrument that can detect FAM and Texas Red like the Cepheid SmartCycler System. The Cepheid Analyte Specific Reagent* (ASR) program is comprised of a series o...Darvon & Metabolite Confirmation/Quantitation, Serum or Plasma
Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...Parvovirus B19 Antibodies Seroconversion, IgG & IgM
Description:ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, maj...GenVec Presents Research on New Ad35 Adenovector at ARVO
GAITHERSBURG, Md.--(BUSINESS WIRE)--May 10, 2007 - GenVec, Inc.(Nasdaq:GNVC) today announced pre-clinical research demonstratingthe ability of the Company's new adenovector, Ad35, to induce andsustain protein production in the eye. Lisa L. Wei, Ph.D., GenVec'sDirector of Pre-Clinical Research, presented a poster, AlternateSerotype Adenovector Gives Long-Term Expression in the Eye, at theAss...VEGF Trap-Eye Phase 2 Wet AMD Results Reported at ARVO Annual Meeting
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--May 9, 2007 - RegeneronPharmaceuticals, Inc. (Nasdaq: REGN) today announced positiveresults from several studies evaluating the VEGF Trap-Eye in theneovascular form of age-related macular degeneration (wet AMD) anddiabetic macular edema (DME). These findings were presented thisweek at the annual meeting of the Association for Research inVision and Oph...Dr. Gabriel Sosne to Present New TB4 Data at 2007 ARVO Meeting
BETHESDA, Md.--(BUSINESS WIRE)--May 7, 2007 - REGENERXBIOPHARMACEUTICALS' (AMEX: RGN), www.regenerx.com - Dr. GabrielSosne will be speaking at the 2007 Association for Research inVision and Ophthalmology (ARVO) meeting in Ft. Lauderdale, Floridaon May 9th to discuss TB4's ability to inhibit corneal neutrophilinfiltration. Neutrophil infiltration is a process closelyassociated with inflammat...